| CAS NO: | 1346452-25-2 |
| 包装: | 1mg |
| 市场价: | 15000元 |
| 生物活性 | Enfortumab vedotin-ejfv is ananti-Nectin-4 antibody-drug conjugatefor the management of urothelial carcinoma[1]. |
| 体外研究 (In Vitro) | Enfortumab vedotin-ejfv is a fully human IgG1-kappa antibody conjugated to the microtubule-disrupting agent, monomethyl auristatin E (MMAE), via a protease-cleavable maleimidocaproyl valine-citrulline linker (SGD-1006)[2]. |
| Clinical Trial | |
| 性状 | Solid |
| CAS 号 | 1346452-25-2 |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
